The Novodiag RESP-4 assay, performed with the Novodiag System, is a cartridge-based molecular test for the detection and differentiation of SARS-CoV-2, Flu A, Flu B and RSV in one single assay. The test uses nasopharyngeal swab samples from patients.
CE marked. Not for sale in the US.
Smart Simplicity in On-demand Testing
Cartridge-based, on-demand testing, that delivers clinical confidence in approximately an hour.
Features & Benefits
The Novodiag® Solution allows a simple and fast way to pinpoint patients most at risk with targeted, multiplex and syndromic on-demand testing.